Pharmacological interventions for premature ejaculation: a mixed-treatment comparison network meta-analysis of randomized clinical trials
Abstract
Premature ejaculation (PE) is the most common sexual dysfunction in men. The present study is a network meta-analysis of drugs used for treating PE. Methods: Electronic databases were searched for randomized controlled trials comparing medical interventions with either placebo or with other active drugs in patients with PE. Consistency between the direct and indirect estimates were checked. Publication bias was assessed. Inverse variance heterogeneity model was used for mixed treatment comparisons. Intravaginal ejaculatory latency time (IELT) and adverse events were the main outcome measures. Odds ratio with 95% confidence intervals was the effect estimate. Grading of the evidence was carried out based on precision, consistency, directness, risk of bias and publication bias of the included studies. Results: A total of 48 studies were included in the meta-analysis. Dapoxetine 30 (1.2, 1-1.4) and 60 mg (1.7, 1.3-2.7), sildenafil (2.6, 1.3-3.9), paroxetine with sildenafil (3, 1.9-4.1), topical lidocaine (3.4, 2-4.7), vardenafil (3.5, 2-5), pindolol with paroxetine (4, 2.8-5.2), tramadol (4.5, 3.3-5.7), topical lidocaine with tadalafil (5.1, 4-6.2) and topical eutectic mixture of local anesthetic (6.4, 2.4-10.5) were associated with significant increase in IELT. Similarly, dapoxetine 60 mg, venlafaxine, fluoxetine, tramadol at 25, 50 and 100 mg and combined fluoxetine and tadalafil were associated with an increased risk of adverse events. Dapoxetine 30 mg has a high likelihood…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Nutritional, Physical, Cognitive, and Combination Interventions and Frailty Reversal Among Older Adults: A Randomized Controlled Trial
- Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
- A randomized, controlled trial of oral propranolol in infantile hemangioma
- Clinical phenotypes of delirium during critical illness and severity of subsequent long-term cognitive impairment: a prospective cohort study
- Increased physical activity improves sleep and mood outcomes in inactive people with insomnia: a randomized controlled trial
- COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.